There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...

With its domination of the indication- and brand-specific analyses, it should come as no surprise that AstraZeneca led the ...

The field of genitourinary (GU) oncology has seen significant developments over recent decades, yet challenges in treatment outcomes remain. Current ...